CVS Health

Q2 FY2026 EarningsQ2 FY2026 beat consensus across all key metrics: total revenue reached $106.1B vs. $100.1B expected, while Adjusted EPS of $2.58 significantly outperformed the $1.85 mean estimate. The performance was driven by a robust recovery in the Health Care Benefits (HCB) segment, where the Medical Benefit Ratio (MBR) improved to 87.4% vs. 89.9% YoY. Consequently, management raised FY2026 Adjusted EPS guidance to $7.90–$8.10, well above the prior range and consensus expectations.